指南与共识创伤与烧伤复苏、休克与脓毒症心脑血管急症

院前创伤汇编:创伤中的血管加压药——NAEMSP 立场声明与资源文件

Prehospital Trauma Compendium: Vasopressors in Trauma - a Position Statement and Resource Document of NAEMSP.
指南 / 共识 · Prehosp Emerg Care · 2024-12-18
一句话结论NAEMSP 指出现有证据不支持 EMS 临床医生对创伤性失血性休克常规使用血管加压药,并提示可能有害。

创伤患者可因失血性、神经源性、梗阻性或混合性机制发生休克,恢复足够灌注对降低并发症和死亡至关重要。NAEMSP 回顾院前创伤相关休克使用血管加压药的证据,形成立场声明。现有证据不支持 EMS 临床医生对创伤性失血性休克常规使用血管加压药,并提示可能有害;现有证据未涉及严重脊髓损伤神经源性休克或院前脊柱损伤患者达到特定平均动脉压目标时使用血管加压药;院前低血压对 TBI 患者有害,但目前无证据支持或反对 EMS 临床医生在 TBI 中使用血管加压药。

要点

  • 现有证据不支持 EMS 临床医生对创伤性失血性休克常规使用血管加压药,并提示可能有害。
  • 现有证据未涉及 EMS 临床医生在严重脊髓损伤神经源性休克或院前达到特定平均动脉压目标时使用血管加压药。
  • 院前低血压对 TBI 患者有害。
  • 目前无证据支持或反对 EMS 临床医生在 TBI 中使用血管加压药。
  • 理论上血管加压药可能用于对液体复苏无效的失血性休克、无血制品可用、神经源性休克或严重脊髓损伤 MAP 目标,但证据不支持常规使用。

适用人群与场景

  • 急性创伤患者,包括失血性休克、TBI 或脊髓损伤所致神经源性休克、张力性气胸或心包填塞所致梗阻性休克或混合机制休克。
  • 院前环境,由 EMS 临床医生评估和处理。

红旗征与不能漏的情况

  • 院前低血压对 TBI 患者有害。

研究设计与关键结果

  • NAEMSP 回顾院前创伤相关休克使用血管加压药的现有证据,形成立场声明与资源文件。
  • 现有证据不支持 EMS 临床医生对创伤性失血性休克常规使用血管加压药,并提示可能有害。
  • 现有证据未涉及 EMS 临床医生在严重脊髓损伤神经源性休克或院前达到特定平均动脉压目标时使用血管加压药。
  • 院前低血压对 TBI 患者有害;目前无证据支持或反对 EMS 临床医生在 TBI 中使用血管加压药。

证据类型、等级与局限

  • 证据类型:立场声明与资源文件(指南/共识)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 现有证据不支持 EMS 临床医生对创伤性失血性休克常规使用血管加压药,并提示可能有害。
  • 现有证据未涉及 EMS 临床医生在严重脊髓损伤神经源性休克或院前达到特定平均动脉压目标时使用血管加压药,不能据此形成推荐。
  • 目前无证据支持或反对 EMS 临床医生在 TBI 中使用血管加压药。

指南或共识出处

  • 指南名称:院前创伤汇编:创伤中的血管加压药——NAEMSP 立场声明与资源文件。
  • 发布机构:美国国家急诊医疗服务医师协会(NAEMSP)。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Acutely injured trauma patients may develop shock from several potential mechanisms, including hypovolemic shock from hemorrhage, neurogenic shock from traumatic brain injury (TBI) or spinal cord injury, obstructive shock from tension pneumothorax or pericardial tamponade, or a mix of several of these mechanisms. Regardless of the cause, restoration of adequate perfusion is of critical importance to reduce the morbidity and mortality of trauma patients with shock. Multiple interventions including hemorrhage control, volume resuscitation with intravenous fluids or blood products, and pleural decompression procedures are used to address some of these issues and are discussed elsewhere in the trauma compendium. The prehospital use of vasopressors to augment organ perfusion pressures seems theoretically appealing for settings where trauma patients have hemorrhagic shock that is refractory to volume resuscitation strategies alone, where blood products are not available, in cases of hypoperfusion caused by neurogenic shock, or to address mean arterial pressure (MAP) goals in severe spinal cord injury. The National Association of Emergency Medical Services Physicians (NAEMSP) reviewed the available evidence surrounding the prehospital use of vasopressors in shock related to trauma to develop the following recommendations as supported by the evidence summarized in the subsequent resource document.

Current evidence does not support the routine use of vasopressors by EMS clinicians for traumatic hemorrhagic shock and suggests the possibility of harm.Current evidence does not address the use of vasopressors by EMS clinicians in the treatment of patients with severe spinal cord injury presenting with neurogenic shock or to achieve specific mean arterial pressure goals in spine injured patients in the prehospital setting.Prehospital hypotension has been shown to be harmful to patients with TBI; however, there is currently no evidence to support or refute the use of vasopressors by EMS clinicians in the setting of TBI.

来源:Prehosp Emerg Care,查看原文。版权归原作者所有。

参考来源

  1. Orpet RE, Barrett WJ, Kaucher KA, et al. Prehospital Trauma Compendium: Vasopressors in Trauma - a Position Statement and Resource Document of NAEMSP. Prehosp Emerg Care. 2024. PMID: 39693581. doi:10.1080/10903127.2024.2437656

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。